{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T19:24:10Z","timestamp":1777577050768,"version":"3.51.4"},"reference-count":14,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2004,10,21]],"date-time":"2004-10-21T00:00:00Z","timestamp":1098316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2004,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p><jats:bold>Background<\/jats:bold> :\u2002Effective symptom control is a primary concern of most heartburn suffers.<\/jats:p><jats:p><jats:bold>Aim<\/jats:bold> :\u2002To compare the safety and efficacy of pantoprazole, placebo and the H<jats:sub>2<\/jats:sub> antagonist nizatidine in relieving symptoms in patients with erosive oesophagitis.<\/jats:p><jats:p><jats:bold>Methods<\/jats:bold> :\u2002Data from two randomized, double\u2010blind studies were pooled. Patients received pantoprazole 10, 20 or 40\u2003mg, or placebo daily (study 1, <jats:italic>n<\/jats:italic>\u2003=\u2003603), or pantoprazole 20 or 40\u2003mg daily or 150\u2010mg nizatidine b.d. (study 2, <jats:italic>n<\/jats:italic>\u2003=\u2003243) for either 4 or 8\u2003weeks. Endoscopy was performed at baseline, week 4 and week 8. Persistent absence of symptoms was defined as the first day that no symptoms were reported by the patient on that day or any subsequent study day.<\/jats:p><jats:p><jats:bold>Results<\/jats:bold> :\u2002A significantly higher percentage (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.05) of pantoprazole patients reported elimination of all symptoms by week 8. Daytime heartburn, night\u2010time heartburn and regurgitation were significantly better controlled with pantoprazole (with a dose\u2013response at most time\u2010points). Absence of symptoms was a powerful predictor of healing; presence of symptoms correlated poorly.<\/jats:p><jats:p><jats:bold>Conclusion<\/jats:bold> :\u2002Pantoprazole is more effective than placebo or nizatidine for controlling heartburn and acid regurgitation in patients with erosive oesophagitis. Relief of GERD symptoms is highly predictive of healing of erosive oesophagitis at 4 and 8\u2003weeks.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2004.02233.x","type":"journal-article","created":{"date-parts":[[2005,3,10]],"date-time":"2005-03-10T04:17:50Z","timestamp":1110428270000},"page":"1105-1114","source":"Crossref","is-referenced-by-count":13,"title":["Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis"],"prefix":"10.1111","volume":"20","author":[{"given":"W. J.","family":"Bochenek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. E.","family":"Mack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. D.","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. C.","family":"Metz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,11,3]]},"reference":[{"key":"e_1_2_20_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01071906"},{"key":"e_1_2_20_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2003.07531.x"},{"key":"e_1_2_20_4_2","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/j.1572-0241.1999.1123_a.x","article-title":"The practice parameters committee of the American College of Gastroenterology. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease","volume":"94","author":"DeVault KR","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_20_5_2","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1001\/archinte.1991.00400030018004","article-title":"Rationale and efficacy of conservative therapy for gastroesophageal reflux disease","volume":"151","author":"Kitchin LI","year":"1991","journal-title":"Arch Intern Med"},{"key":"e_1_2_20_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.18.2331"},{"key":"e_1_2_20_7_2","first-page":"1212","article-title":"Treatment of reflux esophagitis resistant to H2\u2010receptor antagonists with lansoprazole, a new H+\/K(+)\u2010ATPase inhibitor: a controlled, double\u2010blind study. Lansoprazole Study Group","volume":"88","author":"Feldman M","year":"1993","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_20_8_2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jama.1996.03540120061035","article-title":"Gastroesophageal reflux disease","volume":"276","author":"Kahrilas PJ.","year":"1996","journal-title":"JAMA"},{"key":"e_1_2_20_9_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-199856030-00002"},{"key":"e_1_2_20_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)83061-1"},{"key":"e_1_2_20_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(00)82125-3"},{"key":"e_1_2_20_12_2","first-page":"1611","article-title":"Pantoprazole (PAN) is effective in healing of erosive esophagitis (EE) and symptomatic relief in GERD patients (Abstract)","volume":"93","author":"Bochenek WJ","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_20_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.03254.x"},{"issue":"4","key":"e_1_2_20_14_2","first-page":"A125 (Abs G0538","article-title":"Pantoprazole heals erosive esophagitis more effectively and provides greater symptomatic relief than placebo or nizatidine in gastroesophageal reflux disease patients","volume":"116","author":"Bochenek W","year":"1999","journal-title":"Gastroenterology"},{"key":"e_1_2_20_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(88)90162-X"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02233.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02233.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2004.02233.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T23:23:01Z","timestamp":1697239381000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2004.02233.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":14,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["10.1111\/j.1365-2036.2004.02233.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02233.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}